Medpace Holdings (MEDP) Tops Q3 EPS by 17c; Offers Guidance

Medpace Holdings (NASDAQ: MEDP) reported Q3 EPS of $2.22, $0.17 better than the analyst estimate of $2.05. Revenue for the quarter came in at $492.5 million versus the consensus estimate of $475.79 million.

GUIDANCE:

Medpace Holdings sees FY2023 EPS of $8.54-$8.66, versus the consensus of $8.65. Medpace Holdings sees FY2023 revenue of $1.87-1.89 million, versus the consensus of $1.864 million.

For earnings history and earnings-related data on Medpace Holdings (MEDP) click here.

You May Also Be Interested In

• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
• Vivos Therapeutics (VVOS) Tops Q2 EPS by 6c
• Nuvve Holdin (NVVE) Misses Q2 EPS by 1445c